Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges
Open accessAbstract
Natural products derived from plants, as well as their bioactive compounds, have been extensively studied in recent years for their therapeutic potential in a variety of neurodegenerative diseases (NDs), including Alzheimer's (AD), Huntington's (HD), and Parkinson's (PD) disease. These diseases are characterized by progressive dysfunction and loss of neuronal structure and function. There has been little progress in designing efficient treatments, despite impressive breakthroughs in our understanding of NDs. In the prevention and therapy of NDs, the use of natural products may provide great potential opportunities; however, many clinical issues have emerged regarding their use, primarily based on the lack of scientific support or proof of their effectiveness and patient safety. Since neurodegeneration is associated with a myriad of pathological processes, targeting multi-mechanisms of action and neuroprotection approaches that include preventing cell death and restoring the function of damaged neurons should be employed. In the treatment of NDs, including AD and PD, natural products have emerged as potential neuroprotective agents. This current review will highlight the therapeutic potential of numerous natural products and their bioactive compounds thatexert neuroprotective effects on the pathologies of NDs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many natural compounds act as multi-target agents with fewer side effects than synthetic counterparts.
“Many of them have also been demonstrated to act as multi-target agents with reported fewer side effects in comparison to their synthetic counterparts (Rahman et al., 2021)”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Rahman et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415 · see citing works
DLS and zeta potential – What they are and what they are not?
Bhattacharjee, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.017 · Cited by 4,702 · see citing works
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611 · see citing works
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,305 · see citing works
Nita, M., & Grzybowski, A. E. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3164734 · Cited by 1,451 · see citing works
The Role of Polyphenols in Human Health and Food Systems: A Mini-Review
Cory, H., Passarelli, S., Szeto, J., Tamez, M., & Mattei, J. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00087 · Cited by 1,297 · see citing works
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Şener, B., Kılıç, M., Sharifi‐Rad, M., Fokou, P. V. T., Martins, N. A., & Sharifi‐Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,141 · see citing works
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Shahmoradian, S. H., Lewis, A. J., Genoud, C., Hench, J., Moors, T. E., Navarro, P. P., Castaño‐Díez, D., Schweighauser, G., Graff-Meyer, A., Goldie, K. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0423-2 · Cited by 974 · see citing works
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966 · see citing works
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 938 · see citing works
Kaushik, S., & Cuervo, A. M. (2015) · Nature Medicine · doi:10.1038/nm.4001 · Cited by 899 · see citing works
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859 · cited 1× · see citing works
“To summarize, natural products have recently received increasing interest as alternative or integrative treatment agents against AD and other NDs [18,19].”
BackgroundLRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828 · see citing works
Polyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 817 · see citing works
The basal ganglia and the cerebellum: nodes in an integrated network
Bostan, A. C., & Strick, P. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0002-7 · Cited by 786 · see citing works
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J. E., Reynolds, B., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002035 · Cited by 753 · see citing works
Batiha, G. E., Beshbishy, A. M., Ikram, M., Mulla, Z. S., El-Hack, M. E. A., Taha, A. E.-S., Algammal, A. M., & Elewa, Y. H. A. (2020) · Foods · doi:10.3390/foods9030374 · Cited by 716 · see citing works
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M. L., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 712 · see citing works
Buendía, I., Michalska, P., Navarro, E., Gameiro‐Ros, I., Egea, J., & Leon, R. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 683 · see citing works
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications
Cunha, L., & Grenha, A. (2016) · Marine Drugs · doi:10.3390/md14030042 · Cited by 619 · see citing works
Williamson, G., Kay, C. D., & Crozier, A. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12351 · Cited by 607 · see citing works
Selective vulnerability in neurodegenerative diseases
Fu, H., Hardy, J., & Duff, K. E. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0221-2 · Cited by 585 · see citing works
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
Yan, X., Qi, M., Li, P., Zhan, Y., & Shao, H. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0179-x · Cited by 560 · see citing works
Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More
Costa, L. G., Garrick, J. M., Roqué, P. J., & Pellacani, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2986796 · Cited by 550 · see citing works
Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Khan, H. Z., Ullah, H., Aschner, M., Cheang, W. S., & Akkol, E. K. (2019) · Biomolecules · doi:10.3390/biom10010059 · Cited by 541 · see citing works
The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540 · see citing works
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 540 · see citing works
Park, J.-S., Davis, R. L., & Sue, C. M. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0829-3 · Cited by 516 · see citing works
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503 · see citing works
Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo‐Sánchez, E., Daglia, M., Skalicka‐Woźniak, K., & Nabavi, S. M. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.09.002 · Cited by 480 · see citing works
Mechanisms of neurodegeneration in Huntington’s disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 480 · see citing works
Converging pathways in neurodegeneration, from genetics to mechanisms
Gan, L., Cookson, M. R., Petrucelli, L., & Spada, A. R. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 475 · see citing works
Mitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455 · see citing works
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Gelders, G., Baekelandt, V., & Van der Perren, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4784268 · Cited by 430 · see citing works
Marine macroalgae as sources of protein and bioactive compounds in feed for monogastric animals
Øverland, M., Mydland, L. T., & Skrede, A. (2018) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9143 · Cited by 427 · see citing works
Neuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 411 · see citing works
Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
Bhullar, K. S., & Rupasinghe, H. P. V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/891748 · Cited by 411 · see citing works
The amyloid precursor protein: beyond amyloid.
Zheng, H., & Koo, E. H. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-5 · Cited by 403 · see citing works
Singh, R., Parihar, P., Singh, M., Bajguz, A., Kumar, J., Singh, S., Singh, V. P., & Prasad, S. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00515 · Cited by 399 · see citing works
Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence
Hajialyani, M., Farzaei, M. H., Echeverría, J., Nabavi, S. M., Uriarte, E., & Sobarzo‐Sánchez, E. (2019) · Molecules · doi:10.3390/molecules24030648 · Cited by 385 · see citing works
Neuroinflammation: Microglia and T Cells Get Ready to Tango
Schetters, S. T. T., Gómez‐Nicola, D., García-Vallejo, J. J., & van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01905 · Cited by 378 · see citing works
Akhondzadeh, S., Noroozıan, M., Mohammadi, M., Ohadinia, S., Jamshidi, A. H., & Khani, M. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00463.x · Cited by 345 · see citing works
Davidov‐Pardo, G., & McClements, D. J. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.05.003 · Cited by 338 · see citing works
Osellame, L. D., Rahim, A. A., Hargreaves, I. P., Gegg, M. E., Richard-Loendt, A., Brandner, S., Waddington, S. N., Schapira, A. H. V., & Duchen, M. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.014 · Cited by 329 · see citing works
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
Rao, V. K., Carlson, E. A., & Yan, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 325 · see citing works
Resveratrol: A miraculous natural compound for diseases treatment
Koushki, M., Dashatan, N. A., Ahmadi, N., Abbaszadeh, H., & Rezaei–Tavirani, M. (2018) · Food Science & Nutrition · doi:10.1002/fsn3.855 · Cited by 319 · see citing works
SIRT1 Activation by Natural Phytochemicals: An Overview
Iside, C., Scafuro, M., Nebbioso, A., & Altucci, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01225 · Cited by 318 · see citing works
Saleh, A. S. M., Wang, P., Wang, N., et al. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12449 · Cited by 313 · see citing works
Hou, Y., Wang, K., Wan, W., Yue, C., Pu, X., & Ye, X. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.06.001 · Cited by 309 · see citing works
Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi, A.-H., & Khalighi-Cigaroudi, F. (2004) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-4-12 · Cited by 307 · see citing works
Beneficial Effects of Marine Algal Compounds in Cosmeceuticals
Thomas, N. V., & Kim, S. (2013) · Marine Drugs · doi:10.3390/md11010146 · Cited by 305 · see citing works
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Zhang, Y., Huang, N.-Q., Yan, F., Jin, H., Zhou, S.-Y., Shi, J.-S., & Jin, F. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.015 · Cited by 301 · see citing works
Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats
Ishisaka, A., Ichikawa, S., Sakakibara, H., Piskula, M. K., Nakamura, T., Kato, Y., Ito, M., Miyamoto, K.-I., Tsuji, A., Kawai, Y., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.017 · Cited by 293 · see citing works
Harischandra, D. S., Ghaisas, S., Zenitsky, G. D., Jin, H., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00654 · Cited by 290 · see citing works
Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280 · see citing works
Balez, R., Steiner, N., Engel, M., Muñoz, S. S., Lum, J. S., Wu, Y., Wang, D., Vallotton, P., Sachdev, P. S., O’Connor, M. D., et al. (2016) · Scientific Reports · doi:10.1038/srep31450 · Cited by 278 · see citing works
Bioactivity of genistein: A review of in vitro and in vivo studies
Ganai, A. A., & Farooqi, H. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.10.026 · Cited by 274 · see citing works
Exploring Marine Resources for Bioactive Compounds
Kiuru, P. S., D’Auria, M. V., Muller, C. D., Tammela, P., Vuorela, H. J., & Yli‐Kauhaluoma, J. T. (2014) · Planta Medica · doi:10.1055/s-0034-1383001 · Cited by 252 · see citing works
Microglia: Housekeeper of the Central Nervous System
Kabba, J. A., Xu, Y., Christian, H., Ruan, W., Kitchen, C., Xiang, Y., Zhang, L., Saavedra, J. M., & Pang, T. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0504-2 · Cited by 251 · see citing works
Sairazi, N. S. M., & Sirajudeen, K. N. S. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6565396 · Cited by 250 · see citing works
Bagheri, M., Joghataei, M. T., Mohseni, S., & Roghani, M. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.12.001 · Cited by 247 · see citing works
Naturally derived anti-inflammatory compounds from Chinese medicinal plants
Wang, Q., Kuang, H., Su, Y., Sun, Y., Feng, J., Guo, R., & Chan, K. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.12.013 · Cited by 241 · see citing works
Functional ingredients from microalgae
Buono, S., Langellotti, A. L., Martello, A., Rinna, F., & Fogliano, V. (2014) · Food & Function · doi:10.1039/c4fo00125g · Cited by 241 · see citing works
Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease
Zhang, K., Chen, M., Du, Z.-Y., Zheng, X., Li, D., & Zhou, R. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230303 · Cited by 236 · see citing works
Bioaccessibility and bioavailability of phenolic compounds
Shahidi, F., & Peng, H. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.4162 · Cited by 234 · see citing works
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Roy, N. K., Parama, D., Banik, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174101 · Cited by 233 · see citing works
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Brichta, L., Greengard, P., & Flajolet, M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.003 · Cited by 224 · see citing works
Apigenin as neuroprotective agent: Of mice and men
Nabavi, S. F., Khan, H. Z., D’Onofrio, G., Šamec, D., Shirooie, S., Dehpour, A. R., Argüelles, S., Habtemariam, S., & Sobarzo‐Sánchez, E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.008 · Cited by 221 · see citing works
Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
Grieco, M., Giorgi, A., Gentile, M. C., d’Erme, M., Morano, S., Maras, B., & Filardi, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01112 · Cited by 218 · cited 1× · see citing works
“To summarize, natural products have recently received increasing interest as alternative or integrative treatment agents against AD and other NDs [18,19].”
BackgroundChoudhary, D., Bhattacharyya, S., & Bose, S. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1284970 · Cited by 215 · see citing works
Leszek, J., E. Barreto, G., G|siorowski, K., Koutsouraki, E., Ávila-Rodrigues, M., & Aliev, G. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160202125914 · Cited by 206 · cited 1× · see citing works
“Furthermore, the pathophysiology of NDs can also include neuroinflammation [34,35].”
BackgroundDopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
Haddad, F., Sawalha, M., Khawaja, Y., Najjar, A., & Karaman, R. (2017) · Molecules · doi:10.3390/molecules23010040 · Cited by 206 · see citing works
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Rehman, M., Wali, A., Ahmad, A., Shakeel, S., Rasool, S., Ali, R., Rashid, S. M., Madkhali, H. A., Ganaie, M., & Khan, R. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180911124605 · Cited by 202 · see citing works
The Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation
Çalış, Z., Moğulkoç, R., & Baltacı, A. K. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190617150051 · Cited by 197 · see citing works
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Rahman, M. H., Akter, R., Bhattacharya, T., Abdel‐Daim, M. M., Alkahtani, S. H., Arafah, M. W., AL–Johani, N. S., Alhoshani, N. M., Alkeraishan, N., Alhenaky, A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619024 · Cited by 194 · see citing works
Self-citationFormulations of Curcumin Nanoparticles for Brain Diseases
Del Prado-Audelo, M. L., Caballero-Florán, I. H., Meza-Toledo, J. A., Mendoza-Muñoz, N., González-Torres, M., Florán, B., Cortés, H., & Leyva-Gómez, G. (2019) · Biomolecules · doi:10.3390/biom9020056 · Cited by 191 · see citing works
Impaired intracellular trafficking defines early Parkinson's disease
Hunn, B. H. M., Cragg, S. J., Bolam, J. P., Spillantini, M., & Wade‐Martins, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.009 · Cited by 185 · see citing works
Neuroprotective effects of the antiparkinson drug Mucuna pruriens
Manyam, B. V., Dhanasekaran, M., & Hare, T. A. (2004) · Phytotherapy Research · doi:10.1002/ptr.1514 · Cited by 185 · see citing works
Thurgur, H., & Pinteaux, E. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.046 · Cited by 181 · see citing works
Clinical development of curcumin in neurodegenerative disease
Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179 · see citing works
Wattanathorn, J., Mator, L., Muchimapura, S., Tong-un, T., Pasurivong, O., Piyawatkul, N., Yimtae, K., Sripanidkulchai, B., & Singkhoraard, J. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.11.038 · Cited by 179 · see citing works
Thenmozhi, A. J., Raja, T. R. W., Manivasagam, T., Janakiraman, U., & Essa, M. M. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1144846 · Cited by 173 · see citing works
Resveratrol neuroprotection in stroke and traumatic CNS injury
Lopez, M. S., Dempsey, R. J., & Vemuganti, R. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.009 · Cited by 171 · see citing works
Barbosa, A. I., Coutinho, A. J., Lima, S. A. C., & Reis, S. (2019) · Marine Drugs · doi:10.3390/md17120654 · Cited by 166 · see citing works
In vitro–in vivo correlation: Perspectives on model development
Lü, Y., Kim, S., & Park, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.010 · Cited by 165 · see citing works
Ojha, S. K., Javed, H., Azimullah, S., & Haque, M. E. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2733-y · Cited by 165 · see citing works
Niu, X.-Q., Chen, J.-J., & Gao, J.-Q. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.09.005 · Cited by 161 · see citing works
Bhatt, R., Singh, D., Prakash, A. K., & Mishra, N. (2014) · Drug Delivery · doi:10.3109/10717544.2014.880860 · Cited by 160 · see citing works
Ullah, R., Khan, M., Shah, S. A., Saeed, K. M., & Kim, M. O. (2019) · Nutrients · doi:10.3390/nu11061195 · Cited by 154 · see citing works
Hannan, M. A., Dash, R., Haque, M. N., Mohibbullah, M., Sohag, A. A. M., Rahman, M. A., Uddin, M. J., Alam, M., & Moon, I. S. (2020) · Marine Drugs · doi:10.3390/md18070347 · Cited by 152 · see citing works
Self-citationAli, T., Yoon, G. H., Shah, S. A., Lee, H. Y., & Kim, M. O. (2015) · Scientific Reports · doi:10.1038/srep11708 · Cited by 146 · see citing works
Natural product for the treatment of Alzheimer’s disease
Bui, T. T., & Nguyễn, T. H. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0147 · Cited by 146 · see citing works
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Ma, T., Tan, M., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/350516 · Cited by 144 · see citing works
Panov, A., Dikalov, S., Shalbuyeva, N., Hemendinger, R., Greenamyre, J. T., & Rosenfeld, J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00202.2006 · Cited by 141 · see citing works
Durrenberger, P. F., Fernando, F. S., Kashefi, S. N., Bonnert, T. P., Seilhean, D., Nait‐Oumesmar, B., Schmitt, A., Gebicke‐Haerter, P. J., Falkai, P., Grünblatt, E., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1293-0 · Cited by 139 · see citing works
Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu, S., Gao, Z., Weng, Z., Du, Z., Xu, W. A., Yang, J., Zhang, M. L., Tong, Z. H., Fang, Y., & Chai, X. S. (1995) · PubMed · Cited by 137 · see citing works
Quercetin in Food: Possible Mechanisms of Its Effect on Memory
Babaei, F., Mirzababaei, M., & Nassiri‐Asl, M. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14317 · Cited by 137 · see citing works
Ovais, M., Zia, N., Ahmad, I., Khalil, A. T., Raza, A., Ayaz, M., Sadiq, A., Ullah, F., & Shinwari, Z. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00284 · Cited by 137 · see citing works
Dawczynski, C., Schäfer, U., Leiterer, M., & Jahreis, G. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0721500 · Cited by 134 · see citing works
The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients
Boskabady, M. H., Javan, H., Sajady, M., et al. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00509.x · Cited by 132 · see citing works
Flavonoid transport across RBE4 cells: A blood-brain barrier model
Faria, A., Pestana, D., Teixeira, D., Azevedo, J., de Freitas, V. A. P., Mateus, N. F. D. C. B., & Calhau, C. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0006-4 · Cited by 130 · see citing works
Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus
Rimbau, V., Camins, A., Romay, C., González, R., & Pallàs, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00792-2 · Cited by 130 · see citing works
Brain Iron Metabolism and CNS Diseases
Thirupathi, A., & Chang, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_1 · Cited by 127 · see citing works
Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases
Mariane Lutz, R., Eduardo Fuentes, Q., Ávila, F., Alarcón, M. A., & Palomo, I. F. (2019) · Molecules · doi:10.3390/molecules24020366 · Cited by 126 · see citing works
Gender Disparities in Health Care
Kent, J. A., Patel, V., & Varela, N. A. (2012) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.21336 · Cited by 122 · see citing works
Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases
Renaud, J., & Martinoli, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081883 · Cited by 122 · see citing works
Zhang, L., Hao, J., Zheng, Y., Su, R., Liao, Y., Gong, X., Liu, L., & Wang, X. (2018) · Aging and Disease · doi:10.14336/ad.2017.0831 · Cited by 120 · see citing works
Wei, H., Gao, Z., Zheng, L., Zhang, C., Liu, Z., Yang, Y., Teng, H., Hou, L., Yin, Y., & Zou, X. (2017) · Marine Drugs · doi:10.3390/md15030077 · Cited by 119 · see citing works
Modulation of Nrf2 by Olive Oil and Wine Polyphenols and Neuroprotection
Martínez‐Huélamo, M., Rodríguez-Morató, J., Boronat, A., & de la Torre, R. (2017) · Antioxidants · doi:10.3390/antiox6040073 · Cited by 118 · see citing works
de la Rubia Ortí, J. E., García-Pardo, M. P., Drehmer, E., Sancho Cantus, D., Julián Rochina, M., Aguilar, M. A., & Hu Yang, I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180184 · Cited by 116 · see citing works
Effects of turmeric on Alzheimer′s disease with behavioral and psychological symptoms of dementia
Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., Tuji, Y., Niwa, H., Murakami, N., & Krishna, U. (2012) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.110524 · Cited by 115 · see citing works
Ferri, P., Angelino, D., Gennari, L., Benedetti, S., Ambrogini, P., Grande, P. D., & Ninfali, P. (2014) · Food & Function · doi:10.1039/c4fo00817k · Cited by 115 · see citing works
Kosaraju, J., Chinni, S., Roy, P., Kannan, E., Antony, A., & Kumar, M. N. S. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.129312 · Cited by 113 · see citing works
Cell Death Mechanisms of Neurodegeneration
Fan, J., Dawson, T. M., & Dawson, V. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_16 · Cited by 112 · see citing works
Saito, S., Yamamoto, Y., Maki, T., Hattori, Y., Ito, H., Mizuno, K., Harada-Shiba, M., Kalaria, R. N., Fukushima, M., Takahashi, R., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0429-5 · Cited by 110 · see citing works
Exploring the efficacy of natural products in alleviating Alzheimer’s disease
Singh, A., Deshpande, P., & Gogia, N. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253509 · Cited by 108 · see citing works
Cao, Z., Wang, F., Xiu, C., Zhang, J., & Li, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.022 · Cited by 106 · see citing works
Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge
Paolo, M. D., Papi, L., Gori, F., & Turillazzi, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205170 · Cited by 104 · see citing works
Nathan, P. J., Clarke, J., Lloyd, J., Hutchison, C. W., Downey, L., & Stough, C. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.306 · Cited by 103 · see citing works
Ren, Z., Zhao, Y.-F., Cao, T., & Zhen, X.-C. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.42 · Cited by 101 · see citing works
Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MSn
Yang, P., Xu, F., Li, H., Wang, Y., Li, F., Shang, M., Liu, G., Wang, X., & Cai, S. (2016) · Molecules · doi:10.3390/molecules21091209 · Cited by 101 · see citing works
Shim, J. S., Kim, H. G., Ju, M. S., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.023 · Cited by 100 · see citing works
A critical review on grape polyphenols for neuroprotection: Strategies to enhance bioefficacy
Zhao, D., Simon, J. E., & Wu, Q. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1546668 · Cited by 99 · see citing works
Insights into GABA A ergic system alteration in Huntington's disease
Hsu, Y., Chang, Y., & Chern, Y. (2018) · Open Biology · doi:10.1098/rsob.180165 · Cited by 97 · see citing works
Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs
Kumar, G. P., Anilakumar, K. R., & Naveen, S. (2015) · Pharmacognosy Journal · doi:10.5530/pj.2015.1.1 · Cited by 94 · see citing works
Yang, W., Ip, S., Liu, L., Xian, Y., & Lin, Z. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190704092841 · Cited by 92 · see citing works
Role of Dietary Supplements in the Management of Parkinson’s Disease
Ciulla, M., Marinelli, L., Cacciatore, I., & Stefano, A. D. (2019) · Biomolecules · doi:10.3390/biom9070271 · Cited by 92 · see citing works
Mori, M. A., Delattre, A. M., Carabelli, B., Pudell, C., Bortolanza, M., Staziaki, P. V., Visentainer, J. V., Montanher, P. F., Del Bel, E. A., & Ferraz, A. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1290928 · Cited by 89 · see citing works
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Khan, A., Jahan, S., Imtiyaz, Z., Alshahrani, S., Makeen, H. A., Alshehri, B., Kumar, A., Arafah, A. M., & Rehman, M. U. (2020) · Biomedicines · doi:10.3390/biomedicines8080284 · Cited by 89 · see citing works
Uddin, M. S., Hossain, M. F., Mamun, A. A., Shah, M. A., Hasana, S., Bulbul, I. J., Sarwar, M. S., Mansouri, R. A., Ashraf, G. M., Rauf, A., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138313 · Cited by 88 · see citing works
Gadd, M. E., Broekemeier, K. M., Crouser, E. D., Kumar, J., Graff, G., & Pfeiffer, D. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510845200 · Cited by 87 · see citing works
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130216 · Cited by 86 · see citing works
Sirangelo, I., & Iannuzzi, C. (2017) · Molecules · doi:10.3390/molecules22091429 · Cited by 85 · see citing works
Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders
Rakotoarisoa, M., & Angelova, A. (2018) · Medicines · doi:10.3390/medicines5040126 · Cited by 84 · see citing works
Sánchez‐Marzo, N., Pérez-Sánchez, A., Ruiz-Torres, V., Martínez-Tébar, A., Castillo, J., Herranz‐López, M., & Barrajón‐Catalán, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092148 · Cited by 84 · see citing works
Xian, Y., Lin, Z.-X., Mao, Q., Hu, Z. J., Zhao, M., Che, C., & Ip, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/802625 · Cited by 82 · see citing works
Benefits of hesperidin in central nervous system disorders: a review
Kim, J., Wie, M., Ahn, M., Tanaka, A., Matsuda, H., & Shin, T. (2019) · Anatomy & Cell Biology · doi:10.5115/acb.19.119 · Cited by 77 · see citing works
Kim, K. H., Dodsworth, C., Paras, A., et al. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.06.012 · Cited by 75 · see citing works
Metal-deficient SOD1 in amyotrophic lateral sclerosis
Hilton, J. B. W., White, A. R., & Crouch, P. J. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1273-3 · Cited by 75 · see citing works
Neuroprotective Effects of Anthraquinones from Rhubarb in Central Nervous System Diseases
Li, X., Chu, S., Liu, Y., & Chen, N. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3790728 · Cited by 74 · see citing works
Improved delivery of poorly soluble compounds using nanoparticle technology: a review
Kalepu, S., & Nekkanti, V. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0283-1 · Cited by 72 · see citing works
Leonoudakis, D., Rane, A., Angeli, S., Lithgow, G. J., Andersen, J. K., & Chinta, S. J. (2017) · Mediators of Inflammation · doi:10.1155/2017/8302636 · Cited by 72 · see citing works
Marangoni, D., Falsini, B., Piccardi, M., Ambrosio, L., Minnella, A. M., Savastano, M. C., Bisti, S., Maccarone, R., Fadda, A., Mello, E., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-228 · Cited by 70 · see citing works
Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems.
Bagli, E., GOUSSIA, A. C., Moschos, M. M., Agnantis, N. J., & Kitsos, G. (2016) · PubMed · Cited by 70 · see citing works
Silva, J., Alves, C., Pintéus, S., Mendes, S., & Pedrosa, R. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2103-2 · Cited by 70 · see citing works
Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols
Rigacci, S., & Stefani, M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.986101 · Cited by 69 · see citing works
Neuroprotective strategies against calpain-mediated neurodegeneration
Yıldız, A., Korulu, Ş., & Karabay, A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78226 · Cited by 67 · see citing works
Dietary Polyphenols for Treatment of Alzheimer’s Disease– Future Research and Development
Malar, D. S., & Devi, K. P. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140813122703 · Cited by 67 · see citing works
Recent Advances in Self-Assembled Nanoparticles for Drug Delivery
Varma, L. T., Singh, N., Gorain, B., Choudhury, H., Tambuwala, M. M., Kesharwani, P., & Shukla, R. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200210122340 · Cited by 67 · see citing works
Cárdenas, C., Lovy, A., Silva-Pavez, E., Urra, F. A., Mizzoni, C., Ahumada-Castro, U., Bustos, G., Jaña, F., Cruz, P., Farías, P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay1212 · Cited by 66 · see citing works
Diet and Brain Health: Which Role for Polyphenols?
Castelli, V., Grassi, D., Bocale, R., d'Angelo, M., Antonosante, A., Cimini, A., Ferri, C., & Desideri, G. (2017) · Current pharmaceutical design · doi:10.2174/1381612824666171213100449 · Cited by 64 · see citing works
Kumar, A., Lalitha, S., & Mishra, J. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.132180 · Cited by 62 · see citing works
Saha, A., Sarkar, C., SINGH, S. P., Zhang, Z., Munasinghe, J., Peng, S., Chandra, G., Kong, E., & Mukherjee, A. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds038 · Cited by 62 · see citing works
Ferreira, P. E. B., Beraldi, E. J., Borges, S. C., Natali, M. R. M., & Buttow, N. C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.030 · Cited by 62 · see citing works
Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease
Huang, C., Zhang, Z., & Cui, W. (2019) · Marine Drugs · doi:10.3390/md17040221 · Cited by 62 · see citing works
Hannan, M. A., Dash, R., Haque, M. N., et al. (2020) · Preprints.org · doi:10.20944/preprints202005.0342.v1 · Cited by 60 · see citing works
Wu, J., Ai, C., Liu, Y., Zhang, Y., Jiang, M., Fan, X., Ai-ping, L., & Yang, L. (2012) · Current Drug Metabolism · doi:10.2174/1389200211209050599 · Cited by 59 · see citing works
Natural Products as Potential Anti-Alzheimer Agents
Panda, S. S., & Jhanji, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618113613 · Cited by 58 · see citing works
Zhang, F., Xie, J.-X., Lu, J., & Zhang, J.-G. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.152387 · Cited by 57 · see citing works
Lan, Y., Zhou, J., Liu, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490837 · Cited by 56 · see citing works
Natural Products and Neuroprotection
Angeloni, C., & Vauzour, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225570 · Cited by 56 · see citing works
Rahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Thi, T. T., Akter, R., Goh, S. H., Kim, C.-S., & Lee, K. (2021) · Processes · doi:10.3390/pr9020308 · Cited by 56 · see citing works
Self-citationAlteration of the nuclear pore complex in Ca2+-mediated cell death
Bano, D., Dinsdale, D. D., Cabrera‐Socorro, A., Maida, S., Lambacher, N. J., McColl, B. W., Ferrando‐May, E., Hengartner, M. O., & Nicotera, P. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.112 · Cited by 55 · see citing works
Jurcău, A. (2021) · Nutrients · doi:10.3390/nu13020282 · Cited by 55 · see citing works
Ioniță, R., Postu, P. A., Mihăşan, M., Gorgan, L., Hăncianu, M., Cioancă, O., & Hriţcu, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.049 · Cited by 54 · see citing works
Hou, Y., Zhang, Y., Mi, Y., Wang, J., Zhang, H., Xu, J., Yang, Y., Liu, J., Ding, L., Yang, J., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801380 · Cited by 54 · see citing works
Polyphenols Nanoencapsulation for Therapeutic Applications
Salle, A. D. (2016) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000139 · Cited by 53 · see citing works
The flavonoid apigenin delays forgetting of passive avoidance conditioning in rats
Popović, M., Caballero‐Bleda, M., Benavente-García, O., & Castillo, J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113512040 · Cited by 51 · see citing works
Jiang, C.-Y., Qin, X., Yuan, M.-M., Lu, G.-J., & Cheng, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9501427 · Cited by 51 · see citing works
Chamorro, G., Pérez-Albiter, M., Serrano-García, N., Mares-Sámano, J. J., & Rojas, P. (2006) · Nutritional Neuroscience · doi:10.1080/10284150600929748 · Cited by 50 · see citing works
Koh, E.-J., Seo, Y.-J., Choi, J., Lee, H. Y., Kang, D.-H., Kim, K.-J., & Lee, B.-Y. (2017) · Molecules · doi:10.3390/molecules22081363 · Cited by 49 · see citing works
Chonpathompikunlert, P., Boonruamkaew, P., Sukketsiri, W., Hutamekalin, P., & Sroyraya, M. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2166-0 · Cited by 49 · see citing works
Gender disparities in health care
Friedman, E. H. (1991) · JAMA · doi:10.1001/jama.266.21.2984b · Cited by 49 · see citing works
Koh, E.-J., Kim, K.-J., Song, J.-H., Choi, J., Lee, H., Kang, D.-H., Heo, H., & Lee, B.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112401 · Cited by 48 · see citing works
Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model
Zhang, G., Liu, Y., Xu, L., Sha, C., Zhang, H., & Xu, W. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0502-1 · Cited by 48 · see citing works
Chang, C.-Y., Lin, T.-Y., Lu, C.-W., Huang, S.-K., Wang, Y.-C., Chou, S. P., & Wang, S.-J. (2015) · Neurotoxicology · doi:10.1016/j.neuro.2015.08.014 · Cited by 47 · see citing works
Huntingtin gene repeat size variations affect risk of lifetime depression
Gardiner, S. L., van Belzen, M. J., Boogaard, M. W., van Roon‐Mom, W., Rozing, M. P., van Hemert, A. M., Smit, J. H., Beekman, A. T. F., van Grootheest, G., Schoevers, R. A., et al. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0042-1 · Cited by 47 · see citing works
Sarbishegi, M., Gorgich, E. A. C., Khajavi, O., Komeili, G., & Salimi, S. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0131-0 · Cited by 46 · see citing works
Pham, L., Wright, D. K., O’Brien, W. T., Bain, J., Huang, C., Sun, M., Casillas-Espinosa, P. M., Shah, A. D., Schittenhelm, R. B., Sobey, C. G., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105151 · Cited by 44 · see citing works
You, F., Li, Q., Jin, G., et al. (2017) · BMC Neuroscience · doi:10.1186/s12868-016-0329-9 · Cited by 43 · see citing works
Efficacy of Natural Compounds in Neurodegenerative Disorders
Srivastava, P., & Yadav, R. S. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_7 · Cited by 41 · see citing works
Sathya, M., Ponnusamy, M., Palanisamy, P., Kandasamy, M., Jayachandran, K. S., & Anusuyadevi, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161034 · Cited by 41 · see citing works
Wang, Y., Wang, Q., Bao, X., Ding, Y., Shentu, J., Cui, W., Chen, X., Wei, X., & Xu, S. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0207-5 · Cited by 41 · see citing works
Zhang, L., Zhou, Z., Zhai, W., Pang, J., Mo, Y., Yang, G., Qu, Z., & Hu, Y. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00398-0 · Cited by 41 · see citing works
Wang, Y., Dong, P., Liang, J., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.006 · Cited by 39 · see citing works
Lv, L., Yang, F., Li, H., & Yuan, J. (2020) · IUBMB Life · doi:10.1002/iub.2330 · Cited by 39 · see citing works
Bisht, R., Joshi, B. C., Kalia, A. N., & Prakash, A. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0084-z · Cited by 37 · see citing works
Shan, C.-S., Zhang, H., Xu, Q., Shi, Y., Wang, Y., Li, Y., Lin, Y., & Zheng, G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00349 · Cited by 37 · see citing works
Yulyana, Y., Tovmasyan, A. G., Ho, I. A. W., et al. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9628-2 · Cited by 36 · see citing works
Marco, F. D., Romeo, S., Nandasena, C., Purushothuman, S., Adams, C., Bisti, S., & Stone, J. (2013) · Europe PMC (PubMed Central) · Cited by 33 · see citing works
Pal, S., & Paul, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.102 · Cited by 33 · see citing works
Akter, R., Chowdhury, M. A. R., & Rahman, M. H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201102102810 · Cited by 33 · see citing works
Self-citationMoradi-Kor, N., Ghanbari, A., Rashidipour, H., Bandegi, A. R., Yousefi, B., Barati, M., Kokhaei, P., & Rashidy-Pour, A. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s237378 · Cited by 32 · see citing works
Zhang, Y., Yang, Y., Xu, W., & Yang, X.-W. (2017) · Molecules · doi:10.3390/molecules22111944 · Cited by 31 · see citing works
Choi, W. Y., Kang, D. H., & Lee, H.-Y. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7218504 · Cited by 30 · see citing works
A Study for Therapeutic Treatment against Parkinson’s Disease via Chou’s 5-steps Rule
Lan, J., Liu, Z., Liao, C., Merkler, D. J., Han, Q., & Li, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191019111528 · Cited by 29 · see citing works
Wang, B., Lu, Y., Wang, R., et al. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113441 · Cited by 26 · see citing works
Zhang, C., Wu, X., Xian, Y., et al. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/4016323 · Cited by 25 · see citing works
Troncoso-Escudero, P., Sepúlveda, D., Pérez-Arancibia, R., Parra, A. V., Arcos, J., Grunenwald, F., & Vidal, R. L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.571185 · Cited by 25 · see citing works
Rahman, M. H., Akter, R., & Kamal, M. A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200722153611 · Cited by 24 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works
- Authors
- Rahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T. T., Akter, R., Jeong, Y. J., Goh, S. H., Kim, C.-S., & Lee, K.-J.
- Affiliations
- Yonsei University (KR)
- Department of Environmental Medical Biology, Wonju College of Medicine, Yonsei University, Wonju 26426, Gangwon-do, Korea
- Corresponding author
- Lee, Kyu-Jae
- ORCID
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-09-02
- Volume
- 26
- Issue
- 17
- Pages
- 5327
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8433718
- OpenAlex
- W3198336939
- Cited by
- 182
- References
- 215
- Citations by year
- 2026: 35 · 2025: 52 · 2024: 42 · 2023: 27 · 2022: 21 · 2021: 5
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Keywords
- natural products, neurodegenerative diseases, neuroprotection, Alzheimer's disease, Parkinson's disease, Huntington's disease, bioactive compounds, phytochemicals, neuroprotective agents, neuronal cell death, multi-target mechanism
- MeSH terms
- Biological Products, Humans, Neuroprotective Agents, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review